NCT02964078 Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT02964013 Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) Status COMPLETED Phase PHASE1
NCT02963610 Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02963090 Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT02960399 Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older Status TERMINATED Phase NA
NCT02957968 Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02956629 Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041) Status TERMINATED Phase PHASE2
NCT02955758 Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02951481 Antimicrobial Stewardship Program for Clostridium Difficile Infection. Status COMPLETED Phase N/A
NCT02945150 Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant Status COMPLETED Phase PHASE4
NCT02939651 A Study of Pembrolizumab in Patients With Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT02934503 Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) Status TERMINATED Phase PHASE2
NCT02925533 Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract Status TERMINATED Phase PHASE1
NCT02925143 Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning Status COMPLETED Phase NA
NCT02922192 Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis Status COMPLETED Phase N/A
NCT02922179 Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics Status COMPLETED Phase N/A